SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-23-030690
Filing Date
2023-08-30
Accepted
2023-08-30 17:22:16
Documents
5

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 16538
2 proxy_001.jpg GRAPHIC 514922
3 proxy_002.jpg GRAPHIC 257965
4 proxy_003.jpg GRAPHIC 1034712
5 proxy_004.jpg GRAPHIC 860121
  Complete submission text file 0001493152-23-030690.txt   3691599
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Hillstream BioPharma Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41210 | Film No.: 231226166
SIC: 2834 Pharmaceutical Preparations